The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Gulfstream Expands Lead in Handle
- DiEmanuele Named to Woodbine's Board
- Ria Antonia Readies for Run Against Boys
- Horizontal Navigation: Blogs and Multimedia
- New Career Plans for Retired Comma to the Top
- Dozen Pointed for $750,000 CashCall Futurity
- Akeed Mofeed Takes HK Cup; Little Mike 9th
- Boat Trip Wins Express; Triple Heater for 2nd
- Dominant Upsets The Fugue in Hong Kong Vase
- Nutritional Management of Insulin Resistance in Horses